Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Pyxis Oncology (PYXS) over the last 5 years, with Dec 2024 value amounting to $59.5 million.

  • Pyxis Oncology's Shares Outstanding (Weighted Average) rose 5.22% to $62.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.0 million, marking a year-over-year increase of 5.22%. This contributed to the annual value of $59.5 million for FY2024, which is 2.29% up from last year.
  • As of FY2024, Pyxis Oncology's Shares Outstanding (Weighted Average) stood at $59.5 million, which was up 2.29% from $58.1 million recorded in FY2023.
  • In the past 5 years, Pyxis Oncology's Shares Outstanding (Weighted Average) ranged from a high of $59.5 million in FY2024 and a low of $30.6 million during FY2020.
  • For the 3-year period, Pyxis Oncology's Shares Outstanding (Weighted Average) averaged around $50.9 million, with its median value being $58.1 million (2023).
  • Data for Pyxis Oncology's Shares Outstanding (Weighted Average) shows a peak YoY surged of 65.64% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Pyxis Oncology's Shares Outstanding (Weighted Average) stood at $30.6 million in 2020, then grew by 7.16% to $32.8 million in 2021, then increased by 7.12% to $35.1 million in 2022, then soared by 65.64% to $58.1 million in 2023, then increased by 2.29% to $59.5 million in 2024.